my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Biotage is a global company specializing in life science research technologies in the areas of medicinal and analytical chemistry and process development. Technologies include microwave synthesizers, automated flash chromatography instruments and cartridges, sorbents, scavengers and reagents and reaction screening instruments. Headquartered in Uppsala, Sweden with subsidiaries in the US, Japan, Germany, UK and several European countries.
The acquisition of Argonaut Technologies in June 2005, has expanded the company’s product offering to include IST Sample Preparation products and Camille reaction screening process development instrumentation.
Biotage stands behind its customers and products with world-class on site service and customer support.
Biotage AB announced its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd.. Yingsheng is mainly focused on independently researching, producing and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry d ... > more
Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November 6, 2019, and will then take over the responsibility for the Biotage group and its + 400 employ ... > more
Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, at a purchase price of approx. USD 18.4 million, corresponding to approx. SEK 153 million, based on an enterprise value of ... > more
Biotage AB announced its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd.. Yingsheng is mainly focused on independently researching, producing and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry d ... more
Tomas Blomquist: New CEO & President of Biotage
Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November 6, 2019, and will then take over the responsibility for the Biotage group and its + 400 employ ... more
Biotage acquires Horizon Technology
Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, at a purchase price of approx. USD 18.4 million, corresponding to approx. SEK 153 million, based on an enterprise value of ... more
Increased synthesis lab productivity through greener and faster flash purification
Biotage® Selekt and Sfär - Flash purification system and consumables more
Biotage® Horizon 5000 - Automated SPE Disk Extraction System more
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The c ... more
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The c ... more
